Author:
Rothenberg M.L.,Kuhn J.G.,Schaaf L.J.,Rodriguez G.I.,Eckhardt S.G.,Villalona-Calero M.A.,Rinaldi D.A.,Hammond L.A.,Hodges S.,Sharma A.,Elfring G.L.,Petit R.G.,Locker P.K.,Miller L.L.,von Hoff D.D.
Reference31 articles.
1. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme;Pommier;Biochim Biophys Acta,1998
2. A model for tumor cell killing by topoisomerase poisons;Zhang;Cancer Cells,1990
3. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts;Thompson;Clin Cancer Res,1997
4. CPT-11 converting enzyme from rat serum Purification and some properties;Tsuji;J Pharmacobiodyn,1991
5. Identification and kinetics of a β-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan;Rivory;Cancer Chemother Pharmacol,1995
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献